As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.
As climate change brings longer droughts, more frequent heat waves and increasingly unpredictable growing conditions to ...
VERAXA Biotech (NASDAQ: VRXA) provided a corporate and pipeline update highlighting progress during the first half of 2026, ...
VERAXA Biotech (NASDAQ: VRXA) announced the initiation of cell line development for its lead BiTAC(R) T-cell engager ...
Preview this article 1 min A Madrid, Spain-based cancer diagnostic firm seeks to grow its footprint to 21,000-square-foot at ...
B.C.’s globally competitive biotech sector is pushing forward with more UBC-spin-off companies that harness both research and ...
The industry contributes $50 billion to the state GDP, and employs 130,000 people across research and manufacturing.
A medicinal chemist at a biotech company decided to take matters into his own hands after a coworker escalated a simple labeling mistake to management. What could have been a minor error turned into a ...
Dr. Jessica Maloh to lead Continuing Medical Education session 'The Biology of Breakouts”; Codex Labs to feature its plant-biotech acne portfolio and Decode.Me integrative dermatology platform ...
Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European ...
Swiss pharma heavyweight Novartis is cutting a very large check. The company has agreed to acquire London-headquartered ...
This cell-like structure can grow, feed, divide and compete. Researchers ponder what it means for the future of synthetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results